Acutaas Chemicals Limited (NSEI: ACUTAAS)
Health Care · Pharmaceuticals · IN
Rs3,160.60
-1.12% today · +110.9% 1Y
Acutaas Chemicals Limited (NSEI: ACUTAAS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.67B and employs 1,007 people.
Over the last twelve months the share price has gained 110.9%, trading between 1.42K and 3.74K.
Tweenvest scores Acutaas Chemicals Limited across four factors: quality 79/100, value 27/100, growth 100/100, dividend 40/100. Its strongest factor is growth.
ACUTAAS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.67B
- Revenue (TTM)
- $154.60M
- P/E
- 67.28
- EPS
- 46.98
- Dividend yield
- 0.08%
- Beta (5Y)
- 0.02
- 52-week high
- Rs3,740.00
- 52-week low
- Rs1,418.60
- Avg volume (3M)
- —
- Shares outstanding
- 81.87M
- Employees
- 1,007
- Next earnings
- —
About Acutaas Chemicals Limited
Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceutical ingredients (APIs) for a wide range of medical treatments, including those for anti-retroviral applications, inflammation, psychiatric conditions, cancer, Parkinson's disease, depression, and blood coagulation disorders. The company also produces a diverse portfolio of specialty chemicals, serving various industries such as battery manufacturing, personal care, agricultural chemicals, protective coatings, electronics, and general industrial processes. Notable offerings in this category include photoresist chemicals for semiconductor fabrication and electrolyte additives essential for lithium battery cells. Additionally, Acutaas Chemicals provides commodity chemicals like parabens and methyl salicylate, among other fine chemicals, which find application in cosmetics, agricultural products, and various chemical sectors. The company was previously known as Ami Organics Limited, changing its name to Acutaas Chemicals Limited in May 2025.
- ISIN
- INE00FF01025
- Founded
- 2004
- Listed since
- Sep 14, 2021
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Harbin Pharmaceutical Group Co., Ltd.SHSE: 600664 | $2.78B | CN¥7.39 | -0.14% |
| Neuland Laboratories LimitedBSE: 524558 | $2.77B | Rs20,879.85 | -2.87% |
| Joincare Pharmaceutical Group Industry Co.,Ltd.SHSE: 600380 | $2.77B | CN¥10.13 | +2.32% |
| Piramal Pharma LimitedNSEI: PPLPHARMA | $2.70B | Rs196.88 | -0.55% |
| Rubicon Research LimitedNSEI: RUBICON | $2.65B | Rs1,548.50 | -5.05% |
| MBX Biosciences, Inc.NasdaqGS: MBX | $2.56B | $53.24 | -9.01% |
| China Resources Double-Crane Pharmaceutical Co.,Ltd.SHSE: 600062 | $2.53B | CN¥16.44 | +1.23% |
| Supernus Pharmaceuticals, Inc.NasdaqGM: SUPN | $2.48B | $42.67 | +0.68% |
Figures last refreshed Oct 11, 2026.